These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37730689)

  • 1. Neuron-derived extracellular vesicles in blood reveal effects of exercise in Alzheimer's disease.
    Delgado-Peraza F; Nogueras-Ortiz C; Simonsen AH; Knight DD; Yao PJ; Goetzl EJ; Jensen CS; Høgh P; Gottrup H; Vestergaard K; Hasselbalch SG; Kapogiannis D
    Alzheimers Res Ther; 2023 Sep; 15(1):156. PubMed ID: 37730689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative assessment of Alzheimer's disease-related biomarkers in plasma and neuron-derived extracellular vesicles: a nested case-control study.
    Manolopoulos A; Delgado-Peraza F; Mustapic M; Pucha KA; Nogueras-Ortiz C; Daskalopoulos A; Knight DD; Leoutsakos JM; Oh ES; Lyketsos CG; Kapogiannis D
    Front Mol Biosci; 2023; 10():1254834. PubMed ID: 37828917
    [No Abstract]   [Full Text] [Related]  

  • 3. Synaptic proteins in neuron-derived extracellular vesicles as biomarkers for Alzheimer's disease: novel methodology and clinical proof of concept.
    Eitan E; Thornton-Wells T; Elgart K; Erden E; Gershun E; Levine A; Volpert O; Azadeh M; Smith DG; Kapogiannis D
    Extracell Vesicles Circ Nucl Acids; 2023 Mar; 4(1):133-150. PubMed ID: 37842184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Amyloid-β and Tau in Alzheimer's Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin® and Donepezil.
    Alvarez XA; Winston CN; Barlow JW; Sarsoza FM; Alvarez I; Aleixandre M; Linares C; García-Fantini M; Kastberger B; Winter S; Rissman RA
    J Alzheimers Dis; 2022; 90(2):705-717. PubMed ID: 36155516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease.
    Serpente M; Fenoglio C; D'Anca M; Arcaro M; Sorrentino F; Visconte C; Arighi A; Fumagalli GG; Porretti L; Cattaneo A; Ciani M; Zanardini R; Benussi L; Ghidoni R; Scarpini E; Galimberti D
    Cells; 2020 Jun; 9(6):. PubMed ID: 32531989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOEε4 impacts up-regulation of brain-derived neurotrophic factor after a six-month stretch and aerobic exercise intervention in mild cognitively impaired elderly African Americans: A pilot study.
    Allard JS; Ntekim O; Johnson SP; Ngwa JS; Bond V; Pinder D; Gillum RF; Fungwe TV; Kwagyan J; Obisesan TO
    Exp Gerontol; 2017 Jan; 87(Pt A):129-136. PubMed ID: 27864047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated matrix metalloproteinase-9 levels in neuronal extracellular vesicles in Alzheimer's disease.
    Gu D; Liu F; Meng M; Zhang L; Gordon ML; Wang Y; Cai L; Zhang N
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1681-1691. PubMed ID: 32790155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronally derived extracellular vesicles: an emerging tool for understanding Alzheimer's disease.
    Watson LS; Hamlett ED; Stone TD; Sims-Robinson C
    Mol Neurodegener; 2019 Jun; 14(1):22. PubMed ID: 31182115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP1A3 as a target for isolating neuron-specific extracellular vesicles from human brain and biofluids.
    You Y; Zhang Z; Sultana N; Ericsson M; Martens YA; Sun M; Kanekiyo T; Ikezu S; Shaffer SA; Ikezu T
    Sci Adv; 2023 Sep; 9(37):eadi3647. PubMed ID: 37713494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal-Derived EV Biomarkers Track Cognitive Decline in Alzheimer's Disease.
    Eren E; Leoutsakos JM; Troncoso J; Lyketsos CG; Oh ES; Kapogiannis D
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuron-derived extracellular vesicles enriched from plasma show altered size and miRNA cargo as a function of antidepressant drug response.
    Saeedi S; Nagy C; Ibrahim P; Théroux JF; Wakid M; Fiori LM; Yang J; Rotzinger S; Foster JA; Mechawar N; Kennedy SH; Turecki G
    Mol Psychiatry; 2021 Dec; 26(12):7417-7424. PubMed ID: 34385599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal levels of mitochondrial proteins in plasma neuronal extracellular vesicles in major depressive disorder.
    Goetzl EJ; Wolkowitz OM; Srihari VH; Reus VI; Goetzl L; Kapogiannis D; Heninger GR; Mellon SH
    Mol Psychiatry; 2021 Dec; 26(12):7355-7362. PubMed ID: 34471251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.
    Peng S; Wuu J; Mufson EJ; Fahnestock M
    J Neurochem; 2005 Jun; 93(6):1412-21. PubMed ID: 15935057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. proBDNF is modified by advanced glycation end products in Alzheimer's disease and causes neuronal apoptosis by inducing p75 neurotrophin receptor processing.
    Fleitas C; Piñol-Ripoll G; Marfull P; Rocandio D; Ferrer I; Rampon C; Egea J; Espinet C
    Mol Brain; 2018 Nov; 11(1):68. PubMed ID: 30428894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations Between ApoEε4 Carrier Status and Serum BDNF Levels--New Insights into the Molecular Mechanism of ApoEε4 Actions in Alzheimer's Disease.
    Liu YH; Jiao SS; Wang YR; Bu XL; Yao XQ; Xiang Y; Wang QH; Wang L; Deng J; Li J; Zhou XF; Zhou HD; Wang YJ
    Mol Neurobiol; 2015; 51(3):1271-7. PubMed ID: 24986007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma.
    Jensen CS; Bahl JM; Østergaard LB; Høgh P; Wermuth L; Heslegrave A; Zetterberg H; Heegaard NHH; Hasselbalch SG; Simonsen AH
    Exp Gerontol; 2019 Jul; 121():91-98. PubMed ID: 30980923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E4-driven effects on inflammatory and neurotrophic factors in peripheral extracellular vesicles from cognitively impaired, no dementia participants who converted to Alzheimer's disease.
    Ben Khedher MR; Haddad M; Laurin D; Ramassamy C
    Alzheimers Dement (N Y); 2021; 7(1):e12124. PubMed ID: 33537405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion from MCI to AD in patients with the APOE ε4 genotype: Prediction by plasma HCY and serum BDNF.
    Zheng L; Kong X; Cui Y; Wei Y; Zhang J; Wei W
    Neurosci Lett; 2016 Jul; 626():19-24. PubMed ID: 27180036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute aerobic exercise increases brain-derived neurotrophic factor levels in elderly with Alzheimer's disease.
    Coelho FG; Vital TM; Stein AM; Arantes FJ; Rueda AV; Camarini R; Teodorov E; Santos-Galduróz RF
    J Alzheimers Dis; 2014; 39(2):401-8. PubMed ID: 24164734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease.
    Steen Jensen C; Portelius E; Siersma V; Høgh P; Wermuth L; Blennow K; Zetterberg H; Waldemar G; Gregers Hasselbalch S; Hviid Simonsen A
    Dement Geriatr Cogn Disord; 2016; 42(3-4):146-158. PubMed ID: 27643858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.